Author

D. Peters

Primary ORCID profile (0009-0005-5608-1289 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

D. PetersiD1 paper · The Ohio State University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Broeks· 1 shared A. Gil-Jimenez· 1 shared B. van Rhijn· 1 shared B. W. M. Cook· 1 shared C. L. Zuur· 1 shared D. J. Vis· 1 shared E. Diken· 1 shared E. Hooijberg· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Broeks

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An mRNA-encoded, long-lasting Interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers

J. D. Beck, M. Diken, M. Suchan, M. Streuber, E. Diken, L. Kolb, L. Allnoch, F. Vascotto, D. Peters, T. Beissert, O. Tuereci, S. Kreiter, M. Vormehr, U. Sahin

The paper shows that long-lasting mRNA-encoded IL2 restores immune responses in MHC class I-deficient cancers by activating neoantigen-specific CD8+ T cells.

bioRxiv · Jul 18, 2023Immunology

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors

A. Gil-Jimenez, N. van Dijk, J. L. Vos, Y. Lubeck, M. L. van Montfoort, D. Peters, E. Hooijberg, A. Broeks, C. L. Zuur, B. van Rhijn, D. J. Vis, M. S. van der Heijden, L. F. A. Wessels

bioRxiv · May 25, 2023Cancer Biology

Combining Bacteriophage and Vancomycin is Efficacious Against MRSA biofilm-like Aggregates Formed in Synovial Fluid

M. Taha, T. Arnaud, S. S. Theriault, D. Peters, L. Wang, W. Chen, T. Lightly, B. W. M. Cook, H. Abdelbary

This study shows that combining bacteriophage Remus and vancomycin effectively reduces MRSA biofilm-like aggregates in both in vitro and in vivo models.

bioRxiv · May 15, 2023Microbiology